US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity

被引:0
|
作者
G Gomez
F C Stanford
机构
[1] Brigham and Women’s Hospital,Department of Surgery
[2] Harvard Medical School,Urology
[3] Weight Center,Department of Medicine
[4] Gastrointestinal Unit,Department of Pediatrics
[5] Massachusetts General Hospital,Endocrinology
[6] Massachusetts General Hospital,undefined
[7] Harvard Medical School,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:495 / 500
页数:5
相关论文
共 50 条
  • [23] US FDA-approved drug could boost cancer vaccine's efficacy
    Purslow, Caroline
    WOMENS HEALTH, 2012, 8 (04) : 357 - 358
  • [24] Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000-2020)
    Kim, Jeeyun A.
    Ceccarelli, Rachel
    Lu, Christine Y.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (03): : 1 - 13
  • [25] Genomic biomarkers in FDA-approved drug labels
    Mummaneni, Padmaja
    Amur, Shashi G.
    Goodsaid, Federico
    Rudman, Allen
    Frueh, Felix W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1088 - 1088
  • [26] A New FDA-approved Antibiotic for Drug-resistant Tuberculosis Treatment
    Ahmed, Faiza
    Andrews, Kim
    Arshad, Dipali
    Nekuri, Praneeth
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (06): : 559 - 560
  • [27] Reviewing the Synthesis and Clinical Application of FDA-Approved Anticancer Medications
    Johariya, Varsha
    Sharma, Shikha
    Mali, Suraj N.
    Banik, Bimal Krishan
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024, 24 (26) : 2255 - 2273
  • [28] Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease
    Faulkner, Michele A.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (08) : 1055 - 1069
  • [29] Analysis of Real World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia
    White, Craig
    Kwong, Winghan Jacqueline
    Armstrong, Hilary
    Behling, Michael
    Niemira, Jeffrey
    Lang, Kathy
    AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (06): : 293 - 300
  • [30] Pharmacogenomic characterization of US FDA-approved cytotoxic drugs
    Peters, Eric J.
    Motsinger-Reif, Alison
    Havener, Tammy M.
    Everitt, Lorraine
    Hardison, Nicholas E.
    Watson, Venita G.
    Wagner, Michael
    Richards, Kristy L.
    Province, Mike A.
    McLeod, Howard L.
    PHARMACOGENOMICS, 2011, 12 (10) : 1407 - 1415